Stock listing

NASDAQ:SPTX Seaport Therapeutics, Inc. Stock

Home listing (NASDAQ) of Seaport Therapeutics, Inc.

Follow Seaport Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SPTX

$18.05 USD -0.26 (-1.4%)

Close on Nov 20, 2026

Past 6 months -9.0% · daily closes, May 1, 2026 – Nov 20, 2026, adjusted for splits
Day range
$17.41 – $18.83 USDNov 20, 2026
Volume
284,271 sharesNov 20, 2026
Market cap
$966.2M USDAt the close on Nov 20, 2026 · price × 53.53M shares outstanding
Traded on an average day
$5.21M USDMedian day 192,796 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Seaport Therapeutics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SPTX · Home$18.05 USD-0.26 (-1.4%)284,271$18.02$18.83$17.41$18.31Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SPTX · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$18.05-0.26-1.4%$18.02$18.83$17.41284,271
$18.31+0.14+0.8%$18.19$19.12$17.84683,621
$18.17-0.95-5.0%$19.01$19.39$17.90278,253
$19.12-0.86-4.3%$19.70$20.15$18.62387,017
$19.98-0.15-0.7%$20.10$20.53$19.56346,855
$20.13-1.18-5.5%$20.99$21.35$19.94228,588
$21.31-0.66-3.0%$21.83$21.83$20.26225,685
$21.97+0.045+0.2%$22.00$22.23$21.05301,047
$21.93+0.425+2.0%$21.89$22.68$21.28306,863
$21.50+1.11+5.4%$20.85$21.75$19.77227,029
$20.39-0.57-2.7%$21.07$21.07$19.88221,060
$20.96+0.76+3.8%$21.61$21.76$20.02336,175
$20.20+0.19+0.9%$20.01$20.56$19.51393,648
$20.01+0.41+2.1%$19.68$21.07$19.13527,902
$19.60-1.50-7.1%$20.96$21.16$19.00549,189
$21.10+0.72+3.5%$20.71$22.09$20.48272,147
$20.38-0.90-4.2%$20.81$21.02$19.53355,270
$21.28+0.45+2.2%$21.00$22.05$20.73219,054
$20.83+0.22+1.1%$20.76$21.69$20.34124,685
$20.61-0.15-0.7%$20.72$20.89$19.99164,566
$20.76+1.03+5.2%$19.74$21.07$19.74131,421
$19.73+0.45+2.3%$19.27$20.13$18.00134,583
$19.28+1.49+8.4%$17.98$19.63$17.56145,273
$17.79-0.04-0.2%$17.83$18.12$17.47145,736
$17.83+0.23+1.3%$17.63$18.00$17.14184,539
$17.60+0.92+5.5%$16.82$17.89$16.61164,911
$16.68+0.60+3.7%$15.98$16.97$15.79208,623
$16.08-1.07-6.2%$17.08$17.62$16.03227,202
$17.15-1.00-5.5%$18.14$18.14$17.04126,005
$18.15+0.24+1.3%$18.00$18.79$17.89171,206
$17.91-0.02-0.1%$17.67$18.46$17.67177,595
$17.93+0.56+3.2%$17.28$18.29$17.07249,080
$17.37-1.13-6.1%$18.50$19.05$17.18243,005
$18.50+0.08+0.4%$18.42$18.90$17.52172,570
$18.42-0.53-2.8%$19.16$19.16$17.85258,702
$18.95-1.22-6.0%$20.12$20.71$18.37330,192
$20.17+1.48+7.9%$18.85$20.75$18.45488,678
$18.69-0.95-4.8%$19.46$19.80$18.57288,869
$19.64-1.88-8.7%$21.31$21.99$19.22284,477
$21.52+0.40+1.9%$22.20$22.44$21.45192,796
$21.12-0.17-0.8%$21.08$21.37$19.93105,737
$21.29-1.10-4.9%$22.12$23.07$21.03179,279
$22.39+1.27+6.0%$21.20$22.67$21.20146,461
$21.12-0.27-1.3%$21.46$21.94$20.28234,265
$21.39-0.43-2.0%$21.88$23.10$21.292,178,493
$21.82-0.32-1.4%$22.46$23.14$21.10205,613
$22.14-0.82-3.6%$23.01$24.61$21.98235,897
$22.96-1.74-7.0%$24.56$24.95$22.63158,970
$24.70+1.36+5.8%$23.33$25.37$23.33174,188
$23.34+0.06+0.3%$23.39$24.36$23.00134,166
$23.28+1.53+7.0%$21.58$23.28$21.58144,714
$21.75-2.31-9.6%$24.14$25.52$21.73316,780
$24.06-0.80-3.2%$24.89$25.43$23.77141,709
$24.86+0.57+2.3%$24.03$25.00$23.63104,337
$24.29-0.62-2.5%$24.80$26.01$23.5886,222
$24.91+1.30+5.5%$23.66$25.21$23.65156,427
$23.61-0.07-0.3%$23.68$24.20$23.24122,756
$23.68-0.36-1.5%$24.14$26.47$23.01117,846
$24.04-2.21-8.4%$26.09$26.87$24.04144,826
$26.25-1.59-5.7%$27.84$28.38$26.06128,656
$27.84+3.01+12.1%$25.11$28.37$24.42135,682
$24.83+0.75+3.1%$24.25$25.42$24.2585,792
$24.08-0.23-0.9%$24.40$26.47$23.46110,488
$24.31+0.275+1.1%$23.81$25.12$23.7883,149
$24.04-0.385-1.6%$24.12$25.45$23.5386,323
Ticker
NASDAQ:SPTX
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Seaport Therapeutics, Inc. news

Seaport Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 14 in all · newest Nov 2, 2026 · oldest 2026
Decks
6 decks · latest November 2026

Where Seaport Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SPTX · Home listing · This pageNASDAQUnited StatesUSD
BOATS:SPTXBOATSUnited StatesUSD

Valuation

Price/book 2.4× against a median of 2.5×: 4th lowest of 8 Biotechnology companies shown. balance Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$675.8M USD
P/E
Not reported
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
2.4×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.72

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Seaport Therapeutics, Inc. · NASDAQ:SPTXUS$966.2MUS$675.8Mn/an/an/a2.4×n/a0.0×0.72
Inhibrx Biosciences, Inc. · NASDAQ:INBXUS$1.02BUS$1.09Bn/a546×n/an/an/an/a1.89
Duality Biotherapeutics, Inc. · HKEX:9606US$992.3MUS$609.0Mn/a4.8×n/a4.6×−170.8%0.3×n/a
Peptron, Inc. · KRX:087010US$985.3MUS$948.0Mn/a211×n/a10.2×−342.2%0.2×n/a
Omeros Corporation · NASDAQ:OMERUS$983.7MUS$920.3M10.0×12.4×n/an/a132.3%n/a1.64
Everest Medicines Ltd. · HKEX:1952US$981.5MUS$1.00Bn/a2.8×183×1.3×−2.2%0.4×n/a
HBM Holdings Ltd. · HKEX:2142US$981.4MUS$711.5M10.7×4.5×8.6×2.4×57.8%0.2×n/a
City Therapeutics, Inc. · NASDAQ:CTYUS$972.4MUS$802.8Mn/a59.2×n/an/a−431.4%n/an/a
MoonLake Immunotherapeutics · NASDAQ:MLTXUS$942.1MUS$543.7Mn/an/an/a2.5×n/a0.3×1.32
Savara, Inc. · NASDAQ:SVRAUS$939.9MUS$840.4Mn/an/an/a8.7×n/a0.3×1.42
Metis TechBio Co., Ltd. Class H · HKEX:7666US$918.1MUS$487.6Mn/a223×n/a2.0×−373.2%0.0×n/a
Median of the othersUS$981.5MUS$821.6M10.4×35.8×95.9×2.5×−170.8%0.3×1.53

Forecasts

7 strong buy · 1 buy · 1 hold · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
37.13 USD · Analysts' mean
EPS, year to Dec 2026
-6.75 · 7 analysts

Team and board

Officers

OfficerRole
Daphne ZoharFounder, CEO & Board Member
Lauren WhiteChief Financial Officer
Antony LoebelChief Medical Officer and President of Clinical Development
Eric GreenChief Operating Officer
Lana GladsteinGeneral Counsel
Shannon CostelloVice President, Communications
Michael ChenCo-founder, Chief Scientific Officer
Steven PaulFounder, Board Chair

Board

DirectorRole
Bob HombachBoard Member
Daphne ZoharFounder, CEO & Board Member
David WheadonBoard Member
Denice TorresBoard Member
Jason PittsBoard Member
Jim HealyBoard Member
Sandi PetersonBoard Member
Sharon MatesBoard Member

Events

QuarterResultsShare move
Q3 2026Nov 2, 2026 · Before open+2.1%
Q2 2026Aug 3, 2026 · Before open+0.9%
Q1 2026Jun 8, 2026 · Before open−1.5%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck40 slidesNovember 2026
Investor Presentation (October 2026)Investor deck40 slidesOctober 2026
Investor Presentation (September 2026)Investor deck40 slidesSeptember 2026
Investor Presentation (September 2026)Investor deck39 slidesSeptember 2026
Investor Presentation (August 2026)Investor deck38 slidesAugust 2026
Investor Presentation (June 2026)Investor deck38 slidesJune 2026

Open Decks

Financings

RaiseDate
Public offering of common stock
Announced: US$254.9M · US$18 a share · Goldman Sachs & Co. LLC +4
Dealers: Goldman Sachs & Co. LLC (co-lead), J.P. Morgan (co-lead), Leerink Partners (co-lead), Citigroup (co-lead), Stifel (co-lead)
May 1, 2026

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$18.00 a share on Apr 30, 2026.

Price
US$18.00 a share
Shares offered
14,160,000 shares of common stock
Offering size
US$254.9 million
Underwriters' option
Up to 2,124,000 more shares
Listing
SPTX on the Nasdaq Global Select Market
Underwriters
Goldman Sachs & Co. LLC, J.P. Morgan, Leerink Partners, Citigroup, Stifel · In the order on the cover
Shares delivered
On or about May 4, 2026

Steps

StepWhen
Draft sent to the SEC in confidenceNov 21, 2025
Filed publiclyApr 10, 2026
Amended onceApr 27, 2026
Shares registered with an exchangeApr 28, 2026
Declared effective by the SECApr 30, 2026
Final prospectus, with the priceMay 1, 2026

Open IPO · From the cover of the final prospectus (424B4) filed May 1, 2026

Filings

FilingDateTypeFiled with
4 · Change in ownershipNov 13, 2026Insider tradeSEC
4 · Change in ownershipNov 4, 2026Insider tradeSEC
10-Q · Quarterly reportNov 2, 2026Quarterly reportSEC
8-K · Current reportNov 2, 2026ResultsSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 5, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 5, 2026Big-stake noticeSEC
10-Q · Quarterly reportAug 3, 2026Quarterly reportSEC
8-K · Current reportAug 3, 2026ResultsSEC
4 · Change in ownershipJun 24, 2026Insider tradeSEC
All 59 filings
FilingDateTypeFiled with
10-Q · Quarterly reportJun 8, 2026Quarterly reportSEC
8-K · Current reportJun 8, 2026ResultsSEC
SCHEDULE 13D · Big-stake noticeMay 11, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 11, 2026Big-stake noticeSEC
3 · Initial statement of ownershipMay 6, 2026Insider tradeSEC
3 · Initial statement of ownershipMay 6, 2026Insider tradeSEC
4 · Change in ownershipMay 6, 2026Insider tradeSEC
SCHEDULE 13D · Big-stake noticeMay 6, 2026Big-stake noticeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
4 · Change in ownershipMay 4, 2026Insider tradeSEC
8-K · Current reportMay 4, 2026Current reportSEC
S-8 · Registration statement for employee plansMay 1, 2026Offer documentSEC
424B4 · ProspectusMay 1, 2026Offer documentSEC
EFFECT · Notice that a registration is effectiveMay 1, 2026Other filingsSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 30, 2026Insider tradeSEC
S-1MEF · Registration of more shares for the same offeringApr 30, 2026Offer documentSEC
CERT · Exchange's certificate of listingApr 30, 2026Other filingsSEC
8-A12B · Registration of shares for listing on an exchangeApr 28, 2026Other filingsSEC
S-1/A · Registration statement, amendedApr 27, 2026Offer documentSEC
S-1 · Registration statementApr 10, 2026Offer documentSEC
DRS/A · Draft registration statement, amendedFeb 27, 2026Offer documentSEC
DRS/A · Draft registration statement, amendedJan 28, 2026Offer documentSEC
DRS · Draft registration statementNov 21, 2025Offer documentSEC
DOct 31, 2024Other filingsSEC

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Seaport Therapeutics, Inc.’s releases · as of Oct 27, 2026

Common shares
53,530,550
Fully diluted
53,530,550

Fully diluted

LineSharesAs of
Common shares53,530,550Oct 27, 2026

Share count over time

CountShares
Oct 27, 202653,530,550

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
ARCH Venture Management, LLC6.29M11.8%US$127MSep 30, 2026
General Atlantic, L.P.6.1M11.4%US$123MSep 30, 2026
Sofinnova Investments, Inc.3.56M6.7%US$71.9MSep 30, 2026
Goldman Sachs2.18M4.1%US$44MSep 30, 2026
Trv Gp VI, LLC2.06M3.9%US$41.6MSep 30, 2026
CPP Investments1.98M3.7%US$39.9MSep 30, 2026
Fidelity1.84M3.4%US$37.1MSep 30, 2026
Foresite Capital Management VI LLC1.78M3.3%US$35.9MSep 30, 2026
JPMorgan1.6M3.0%US$29.8MSep 30, 2026
Jennison Associates LLC1.15M2.2%US$23.2MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Bellevue Group AG1.1M2.1%US$22.2MSep 30, 2026
Siren, L.L.C.1.1M2.0%US$22.1MSep 30, 2026
BlackRock979K1.8%US$19.8MSep 30, 2026
Vanguard799K1.5%US$16.1MSep 30, 2026
Ra Capital Management, L.P.700K1.3%US$14.1MSep 30, 2026
T. Rowe Price633K1.2%US$12.8MSep 30, 2026
Woodline Partners LP587K1.1%US$11.8MSep 30, 2026
Perceptive Advisors LLC500K0.93%US$10.1MSep 30, 2026
Braidwell LP481K0.90%US$9.71MSep 30, 2026
Principal377K0.71%US$7.61MSep 30, 2026
Geode Capital377K0.70%US$7.61MSep 30, 2026
abrdn299K0.56%US$6.02MSep 30, 2026
State Street251K0.47%US$5.06MSep 30, 2026
Seven Grand Managers, LLC225K0.42%US$4.54MSep 30, 2026
Schwab141K0.26%US$2.85MSep 30, 2026
Northern Trust110K0.21%US$2.23MSep 30, 2026
Manufacturers Life Insurance Company, The109K0.20%US$2.2MSep 30, 2026
AdvisorShares Investments LLC94,0000.18%US$1.9MSep 30, 2026
Ameriprise91,2980.17%US$1.84MSep 30, 2026
Alps Advisors Inc70,9210.13%US$1.43MSep 30, 2026
Millennium67,9530.13%US$1.37MSep 30, 2026
TD65,9440.12%US$1.23MSep 30, 2026
Bank of America40,7900.08%US$823KSep 30, 2026
Gsa Capital Partners LLP36,3100.07%US$732KSep 30, 2026
DAFNA Capital Management LLC32,4000.06%US$654KSep 30, 2026
BNY29,4890.06%US$595KSep 30, 2026
Ghisallo Capital Management LLC25,0000.05%US$504KSep 30, 2026
ADAR1 Capital Management, LLC25,0000.05%US$504KSep 30, 2026
Burkehill Global Management, LP25,0000.05%US$504KSep 30, 2026
Citadel24,8430.05%US$501KSep 30, 2026
Quadrature Capital Ltd21,6610.04%US$437KSep 30, 2026
Nuveen18,6030.03%US$375KSep 30, 2026
HighTower Advisors, LLC16,6660.03%US$336KSep 30, 2026
XTX Topco Ltd16,4260.03%US$331KSep 30, 2026
Two Sigma14,5020.03%US$293KSep 30, 2026
Invesco14,1070.03%US$285KSep 30, 2026
UBS12,4630.02%US$251KSep 30, 2026
DWS12,0240.02%US$243KSep 30, 2026
Rhumbline Advisers11,6770.02%US$236KSep 30, 2026
MetLife Investment Management, LLC8,4130.02%US$170KSep 30, 2026

This page holds 50 of 71 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
JPMorgan Small Cap Growth Fund841K1.6%US$18.3MJun 30, 2026
PGIM Jennison Health Sciences Fund439K0.82%US$7.98MMay 29, 2026
Vanguard Total Stock Market Index Fund426K0.80%US$9.26MJun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.299K0.56%US$6.5MJun 30, 2026
JPMorgan Small Cap Blend Fund271K0.51%US$5.9MJun 30, 2026
Fidelity Blue Chip Growth Fund236K0.44%US$4.83MJul 31, 2026
Fidelity Growth Company Fund224K0.42%US$4.08MMay 31, 2026
SmallCap Fund182K0.34%US$3.71MJul 31, 2026
Vanguard Extended Market Index Fund165K0.31%US$3.59MJun 30, 2026
Multi-Manager Small Cap Equity Strategies Fund108K0.20%US$1.96MMay 31, 2026
All 31 holders
HolderSharesOf the companyValueAs of
Fidelity Growth Company K6 Fund62,2960.12%US$1.13MMay 31, 2026
Fidelity Series Growth Company Fund55,9000.10%US$1.02MMay 31, 2026
Fidelity Blue Chip Growth K6 Fund48,1090.09%US$984KJul 31, 2026
Fidelity Series Blue Chip Growth Fund43,7000.08%US$894KJul 31, 2026
Blackstone Alternative Multi-Strategy Fund29,5890.06%US$643KJun 30, 2026
Adara Smaller Companies Fund29,1710.05%US$531KMay 31, 2026
Health Sciences Trust21,0250.04%US$457KJun 30, 2026
T. Rowe Price Health Sciences Portfolio18,4210.03%US$400KJun 30, 2026
Schwab Total Stock Market Index Fund18,0930.03%US$370KJul 31, 2026
Dunham Small Cap Growth Fund17,3720.03%US$355KJul 31, 2026
SmallCap Account16,2000.03%US$352KJun 30, 2026
EQ/T.Rowe Price Health Sciences Portfolio14,8180.03%US$322KJun 30, 2026
Select Biotechnology Portfolio12,7000.02%US$231KMay 31, 2026
Vanguard Russell 2000 Index Fund7,9070.01%US$144KMay 31, 2026
T. Rowe Price Extended Equity Market Index Fund6,3780.01%US$139KJun 30, 2026
Vanguard Institutional Total Stock Market Index Fund4,994<0.01%US$108KJun 30, 2026
Vanguard Balanced Index Fund2,416<0.01%US$52,476Jun 30, 2026
Hypatia Women CEO ETF2,257<0.01%US$46,178Jul 31, 2026
Vanguard Russell 2000 Growth Index Fund778<0.01%US$14,152May 31, 2026
Vanguard Russell 2000 Value Index Fund240<0.01%US$4,366May 31, 2026
Vanguard Russell 3000 Index Fund156<0.01%US$2,838May 31, 2026

Insider trades

TradeTradeSharesPriceValueDate
Torres Denice
Director
Buy5,000USD 19.86US$99,325Nov 3, 2026
Hombach Robert J.
Director
Buy13,000USD 18.14US$236KJun 22, 2026
ARCH Venture Partners XII, L.P.
10% owner
Buy1,100,000USD 18.00US$19.8MMay 4, 2026

Big stakes

StakeStakeSharesDateFiling
PureTech Health plc31.20%16.7MJun 30, 2026Schedule 13G
ARCH Venture Fund XII, L.P.11.90%6.29MMay 4, 2026Schedule 13D
General Atlantic, L.P.11.50%6.1MMay 4, 2026Schedule 13D
Zohar Daphne9.10%5.23MJun 30, 2026Schedule 13G
PAUL STEVEN M6.30%3.52MJun 30, 2026Schedule 13G
Goldman Sachs Group Inc5.50%2.79MMay 6, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
James Healy
Other companies: BioAge Labs, Inc. (Director · Since at least Sep 25, 2024); Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); ArriVent BioPharma, Inc. (Director · Since at least Jan 25, 2024); Y mAbs Therapeutics (Director · Since at least Jun 12, 2019); CinCor Pharma Inc (Director · Jan 6, 2022 – Nov 28, 2022 · Past); Bolt Biotherapeutics, Inc. (Director · Feb 4, 2021 – Jun 12, 2024 · Past); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Coherus Oncology, Inc. (Director · May 22, 2019 – Jan 7, 2022 · Past); Natera, Inc. (Director · Sep 14, 2018 – Apr 25, 2025 · Past)
Director · Since at least Apr 30, 2026
David E. Wheadon
Other companies: Indivior Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); Supernus Pharmaceuticals, Inc. (Director · Since at least Jan 1, 2026); Vaxart, Inc. (Director · Since at least Aug 4, 2022); Sotera Health Company (Director · Since at least May 27, 2022); Karuna Therapeutics Inc (Director · Jun 15, 2022 – Mar 18, 2024 · Past); ChemoCentryx Inc. (Director · May 26, 2022 – Oct 20, 2022 · Past)
Director · Since at least Apr 30, 2026
Denice Torres
Other companies: Celldex Therapeutics, Inc. (Chief Executive Officer; The Ignited Company · Since at least Jun 5, 2025); Glaukos Corporation (Director · Since at least Mar 1, 2021); 2Seventy Bio Inc (Director · Oct 18, 2021 – May 13, 2025 · Past); Surface Oncology Inc (Director · Jul 6, 2021 – Jun 8, 2022 · Past); Karuna Therapeutics Inc (Director · Dec 22, 2020 – Mar 18, 2024 · Past); Bluebird bio Inc (Director · Aug 10, 2020 – Nov 11, 2021 · Past)
Board Member · Since at least Apr 30, 2026
Robert J. Hombach
Other companies: Henry Schein, Inc. (Director · Since at least Jan 29, 2025); Embecta Corp. (Director · Since at least Mar 20, 2022); BioMarin Pharmaceutical Inc. (Director · Since at least Sep 29, 2017); Aptinyx Inc (Director · Jun 20, 2018 – May 26, 2022 · Past); CarMax Inc (Director · Apr 1, 2018 – Jul 2, 2021 · Past); Baxalta Inc (EVP. CFO and COO · Jul 1, 2015 – Jun 3, 2016 · Past)
Director · Since at least Apr 30, 2026
Steve Paul
Other companies: Rapport Therapeutics, Inc. (Director · Since at least Jun 6, 2024); Karuna Therapeutics Inc (Director · Jun 27, 2019 – Mar 18, 2024 · Past); Alnylam Pharmaceuticals, Inc. (Director · Jun 3, 2016 – Apr 1, 2022 · Past); Sigma-Aldrich Corp (Director · Nov 18, 2015 – Nov 18, 2015 · Past); Voyager Therapeutics, Inc. (Director · Nov 10, 2015 – Jun 3, 2021 · Past); Sage Therapeutics Inc (Director · Jul 1, 2015 – Jan 3, 2024 · Past)
Director · Since at least Apr 30, 2026
Sandra E Peterson
Other companies: Microsoft Corp. (Director · Since at least Dec 2, 2015); Zymergen Inc (Director · Apr 21, 2021 – Oct 19, 2022 · Past); Covetrus Inc (Director · Jun 10, 2020 – Oct 13, 2022 · Past); Johnson & Johnson (Exec VP, Group WW Chairman · Dec 1, 2012 – Feb 12, 2018 · Past); Dun & Bradstreet Holdings Inc. (Director · Mar 29, 2007 – Sep 11, 2015 · Past)
Director · Since at least Apr 30, 2026
Atlantic S a r l General
Other companies: Liftoff Mobile, Inc. (Director · Since at least Jun 4, 2026); Alkami Technology, Inc. (Director · Since at least Apr 13, 2021); Centessa Pharmaceuticals PLC (Director · Jun 22, 2023 – Jun 22, 2023 · Past); HireRight Holdings Corp (Director · Nov 16, 2022 – Jun 28, 2024 · Past)
Director · Since at least May 4, 2026
Sharon Mates
Other companies: PureTech Health PLC (Director · Since at least Apr 27, 2026); Benitec Biopharma Inc. (Director · Since at least Nov 3, 2025); Intra-Cellular Therapies Inc (Chairman and CEO, Director · Aug 29, 2013 – Apr 2, 2025 · Past)
Director · Since at least Apr 30, 2026
Daphne Zohar
Other companies: Adicet Bio, Inc. (Director · Jan 25, 2018 – Jan 25, 2018 · Past)
Founder, CEO & Board Member · Since at least Apr 30, 2026
Antony LoebelChief Medical Officer · Since at least May 4, 2026
All 20 people
PersonSeat
Bob HombachBoard Member · Since at least Jun 24, 2026
Eric GreenChief Operating Officer · Since at least Nov 4, 2026
Jason PittsBoard Member · Since at least Nov 5, 2026
Jim HealyBoard Member · Since at least May 4, 2026
Lana GladsteinGeneral Counsel · Since at least May 4, 2026
Lauren WhiteChief Financial Officer · Since at least May 4, 2026
Michael ChenCo-founder, Chief Scientific Officer · Since at least Apr 30, 2026
Sandi PetersonBoard Member · Since at least Nov 5, 2026
Shannon CostelloVice President, Communications · Since at least Oct 9, 2026
Steven PaulFounder, Board Chair · Since at least May 4, 2026

Open People

Log in to ask 6ix AI your own questions about Seaport Therapeutics, Inc.